|
Full Conference Audio Recordings - Plus Slides
Available on USB Flash Drive
This package features audio recordings of all sessions recorded exactly as is happened at the Massachusetts General Hospital Psychiatry Academy "Substance Use Disorders: A Comprehensive Review and Update 2019" Conference, held February 17-20, 2019.
Includes MP3 files of every session. Listen on your computer or fill your iPod or favorite MP3 player with all the live audio from every session. This package allows you to review presentations and is a lasting valuable resource.
BONUS: Also includes slides of sessions in PDF format. |
INCLUDES ALL OF THE PRESENTATIONS FROM THE CONFERENCE:
Item |
Monday, February 18, 2019 |
|
|
Module Topic 1: Empirically Based Methodologies |
31641 |
Motivational Interviewing |
John F. Kelly, PhD |
31642 |
CBT |
John F. Kelly, PhD |
31643 |
Harm Reduction |
Christopher J. Shaw, RN, ANP, PMHNP-BC, CARN-AP |
31644 |
Empirically Based Methodologies Panel Discussion |
Timothy E. Wilens, MD; John F. Kelly, PhD; Christopher J. Shaw, RN, ANP, PMHNP-BC, CARN-AP |
|
Module Topic 2: Recovery Oriented |
|
31645 |
Self-Help Treatments |
John F. Kelly, PhD |
31646 |
Screening |
Christopher J. Shaw, RN, ANP, PMHNP-BC, CARN-AP |
31647 |
Treating Addiction as a Chronic Disease |
Colleen T. LaBelle MSN, RN-BC, CARN |
31648 |
Nursing Clinical Care: The MGH Model |
Christopher J. Shaw, RN, ANP, PMHNP-BC, CARN-AP |
31649 |
Recovery Oriented Panel Discussion |
Timothy E. Wilens, MD; John F. Kelly, PhD; Colleen T. LaBelle MSN, RN-BC, CARN; Christopher J. Shaw, RN, ANP, PMHNP-BC, CARN-AP |
|
Module Topic 3: Pharmacotherapy I |
|
31650 |
Alcohol |
Laura G. Kehoe, MD, MPH, FASAM |
31651 |
Methamphetamine, Cocaine, Stimulants |
Timothy E. Wilens, MD |
31652 |
Pharmacotherapy I Panel Discussion |
John F. Kelly, PhD; Laura G. Kehoe, MD, MPH, FASAM; Timothy E. Wilens, MD |
|
Module Topic 4: Opioid |
|
31653 |
Overview of Opioid Use Disorder |
Colleen T. LaBelle MSN, RN-BC, CARN |
31654 |
Buprenorphine 101 |
Laura G. Kehoe, MD, MPH, FASAM |
31655 |
Naltrexone Intramuscular & Methadone |
Laura G. Kehoe, MD, MPH, FASAM |
31656 |
Opioid Panel Discussion |
Timothy E. Wilens, MD; Laura G. Kehoe, MD, MPH, FASAM; Colleen T. LaBelle MSN, RN-BC, CARN |
Item |
Tuesday, February 19, 2019 |
|
|
Module Topic 5: Neuroscience |
|
31657 |
Neurobiology of Addiction |
Timothy E. Wilens, MD |
31658 |
Genetics of Substance Use Disorders |
Robert R. Althoff, MD, PhD |
31659 |
Neuroscience Panel Discussion |
David H. Rubin, MD; Timothy E. Wilens, MD; Robert R. Althoff, MD, PhD |
|
Module Topic 6: Developmental Perspectives |
|
31660 |
Childhood Precursors |
Robert R. Althoff, MD, PhD |
31661 |
Adolescence |
Timothy E. Wilens, MD |
31662 |
Developmental Perspectives Panel Discussion |
David H. Rubin, MD; Robert R. Althoff, MD, PhD; Timothy E. Wilens, MD |
|
Module Topic 7: Marijuana, Synthetics and Triple C-Legal and Illegal |
31663 |
Medical Marijuana |
Timothy E. Wilens, MD |
31664 |
Contingency Management in Marijuana Addiction |
Robert R. Althoff, MD, PhD |
31665 |
OTC: Synthetics and Triple C |
Timothy E. Wilens, MD |
31666 |
Marijuana, Synthetics and Triple C-Legal and Illegal Panel Discussion |
Laura G. Kehoe, MD, MPH, FASAM; Timothy E. Wilens, MD; Robert R. Althoff, MD, PhD |
|
Module Topic 8: Comorbidity I |
|
31667 |
ADHD |
Timothy E. Wilens, MD |
31668 |
Pain |
Laura G. Kehoe, MD, MPH, FASAM |
31669 |
Pregnancy |
Colleen T. LaBelle, MSN, RN-BC, CARN |
31670 |
Comorbidity I Panel Discussion |
David H. Rubin, MD; Timothy E. Wilens, MD; Laura G. Kehoe, MD, MPH, FASAM; Colleen T. LaBelle, MSN, RN-BC, CARN |
Item |
Wednesday, February 20, 2019 |
|
|
Module Topic 9: Comorbidity II |
|
31671 |
Mood Disorders |
Shamim H. Nejad, MD |
31672 |
Anxiety Disorders |
Shamim H. Nejad, MD |
31673 |
Comorbidity II Question & Answer Session |
Shamim H. Nejad, MD |
|
Module Topic 10: Pharmacotherapy II |
|
31674 |
Withdrawal Management |
Dawn Williamson, RN, MSN, PMHCNS-BC, CARN-AP |
31675 |
Nicotine |
Shamim H. Nejad, MD |
31676 |
Sedatives and Hypnotics |
David H. Rubin, MD |
31677 |
Pharmacotherapy II Panel Discussion |
David H. Rubin, MD; Shamim H. Nejad, MD; Dawn Williamson, RN, MSN, PMHCNS-BC, CARN-AP |
|